UniProt ID | PGK1_HUMAN | |
---|---|---|
UniProt AC | P00558 | |
Protein Name | Phosphoglycerate kinase 1 | |
Gene Name | PGK1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 417 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | In addition to its role as a glycolytic enzyme, it seems that PGK-1 acts as a polymerase alpha cofactor protein (primer recognition protein). [PubMed: 2324090 May play a role in sperm motility] | |
Protein Sequence | MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSLSNKLTL ------CCCCCCCCC | 40.27 | 22814378 | |
2 | Phosphorylation | ------MSLSNKLTL ------CCCCCCCCC | 40.27 | 28464451 | |
4 | Phosphorylation | ----MSLSNKLTLDK ----CCCCCCCCCCC | 25.31 | 28464451 | |
6 | 2-Hydroxyisobutyrylation | --MSLSNKLTLDKLD --CCCCCCCCCCCCC | 39.20 | - | |
6 | Acetylation | --MSLSNKLTLDKLD --CCCCCCCCCCCCC | 39.20 | 26822725 | |
6 | Succinylation | --MSLSNKLTLDKLD --CCCCCCCCCCCCC | 39.20 | - | |
6 | Succinylation | --MSLSNKLTLDKLD --CCCCCCCCCCCCC | 39.20 | - | |
6 | Ubiquitination | --MSLSNKLTLDKLD --CCCCCCCCCCCCC | 39.20 | - | |
8 | Phosphorylation | MSLSNKLTLDKLDVK CCCCCCCCCCCCCCC | 34.22 | 28857561 | |
11 | Ubiquitination | SNKLTLDKLDVKGKR CCCCCCCCCCCCCCE | 50.10 | 21890473 | |
11 | 2-Hydroxyisobutyrylation | SNKLTLDKLDVKGKR CCCCCCCCCCCCCCE | 50.10 | - | |
11 | Acetylation | SNKLTLDKLDVKGKR CCCCCCCCCCCCCCE | 50.10 | 19608861 | |
11 | Ubiquitination | SNKLTLDKLDVKGKR CCCCCCCCCCCCCCE | 50.10 | 21890473 | |
13 | Ubiquitination | KLTLDKLDVKGKRVV CCCCCCCCCCCCEEE | 45.91 | - | |
15 | Acetylation | TLDKLDVKGKRVVMR CCCCCCCCCCEEEEE | 59.38 | 25953088 | |
15 | Malonylation | TLDKLDVKGKRVVMR CCCCCCCCCCEEEEE | 59.38 | 26320211 | |
15 | Ubiquitination | TLDKLDVKGKRVVMR CCCCCCCCCCEEEEE | 59.38 | - | |
17 | Ubiquitination | DKLDVKGKRVVMRVD CCCCCCCCEEEEEEE | 35.98 | - | |
20 | Acetylation | DVKGKRVVMRVDFNV CCCCCEEEEEEEECC | 2.05 | - | |
20 | Ubiquitination | DVKGKRVVMRVDFNV CCCCCEEEEEEEECC | 2.05 | - | |
28 | Ubiquitination | MRVDFNVPMKNNQIT EEEEECCCCCCCCCC | 29.18 | - | |
29 | Sulfoxidation | RVDFNVPMKNNQITN EEEECCCCCCCCCCC | 6.72 | 21406390 | |
30 | Ubiquitination | VDFNVPMKNNQITNN EEECCCCCCCCCCCC | 46.83 | 21890473 | |
30 | 2-Hydroxyisobutyrylation | VDFNVPMKNNQITNN EEECCCCCCCCCCCC | 46.83 | - | |
30 | Acetylation | VDFNVPMKNNQITNN EEECCCCCCCCCCCC | 46.83 | 23954790 | |
30 | Malonylation | VDFNVPMKNNQITNN EEECCCCCCCCCCCC | 46.83 | 26320211 | |
30 | Methylation | VDFNVPMKNNQITNN EEECCCCCCCCCCCC | 46.83 | 22637755 | |
30 | Sumoylation | VDFNVPMKNNQITNN EEECCCCCCCCCCCC | 46.83 | 19608861 | |
30 | Ubiquitination | VDFNVPMKNNQITNN EEECCCCCCCCCCCC | 46.83 | 21890473 | |
35 | O-linked_Glycosylation | PMKNNQITNNQRIKA CCCCCCCCCCHHHHH | 20.53 | 31911580 | |
35 | Phosphorylation | PMKNNQITNNQRIKA CCCCCCCCCCHHHHH | 20.53 | 20071362 | |
39 | Methylation | NQITNNQRIKAAVPS CCCCCCHHHHHHCCC | 34.20 | 115487233 | |
41 | 2-Hydroxyisobutyrylation | ITNNQRIKAAVPSIK CCCCHHHHHHCCCCE | 32.27 | - | |
41 | Malonylation | ITNNQRIKAAVPSIK CCCCHHHHHHCCCCE | 32.27 | 26320211 | |
41 | Ubiquitination | ITNNQRIKAAVPSIK CCCCHHHHHHCCCCE | 32.27 | - | |
46 | O-linked_Glycosylation | RIKAAVPSIKFCLDN HHHHHCCCCEEEECC | 31.63 | 31911580 | |
46 | Phosphorylation | RIKAAVPSIKFCLDN HHHHHCCCCEEEECC | 31.63 | 28985074 | |
47 | Acetylation | IKAAVPSIKFCLDNG HHHHCCCCEEEECCC | 3.03 | - | |
47 | Ubiquitination | IKAAVPSIKFCLDNG HHHHCCCCEEEECCC | 3.03 | - | |
48 | Ubiquitination | KAAVPSIKFCLDNGA HHHCCCCEEEECCCC | 34.07 | 21890473 | |
48 | Acetylation | KAAVPSIKFCLDNGA HHHCCCCEEEECCCC | 34.07 | 19608861 | |
48 | Succinylation | KAAVPSIKFCLDNGA HHHCCCCEEEECCCC | 34.07 | - | |
48 | Succinylation | KAAVPSIKFCLDNGA HHHCCCCEEEECCCC | 34.07 | 19608861 | |
48 | Ubiquitination | KAAVPSIKFCLDNGA HHHCCCCEEEECCCC | 34.07 | 21890473 | |
50 | S-nitrosocysteine | AVPSIKFCLDNGAKS HCCCCEEEECCCCCE | 3.86 | - | |
50 | S-nitrosylation | AVPSIKFCLDNGAKS HCCCCEEEECCCCCE | 3.86 | 22178444 | |
50 | S-palmitoylation | AVPSIKFCLDNGAKS HCCCCEEEECCCCCE | 3.86 | 29575903 | |
56 | 2-Hydroxyisobutyrylation | FCLDNGAKSVVLMSH EEECCCCCEEEEECC | 45.22 | - | |
56 | Acetylation | FCLDNGAKSVVLMSH EEECCCCCEEEEECC | 45.22 | 26051181 | |
56 | Ubiquitination | FCLDNGAKSVVLMSH EEECCCCCEEEEECC | 45.22 | - | |
57 | Phosphorylation | CLDNGAKSVVLMSHL EECCCCCEEEEECCC | 19.54 | 26356563 | |
58 | Ubiquitination | LDNGAKSVVLMSHLG ECCCCCEEEEECCCC | 3.65 | - | |
61 | Sulfoxidation | GAKSVVLMSHLGRPD CCCEEEEECCCCCCC | 1.28 | 30846556 | |
62 | Phosphorylation | AKSVVLMSHLGRPDG CCEEEEECCCCCCCC | 16.05 | 26356563 | |
63 | Acetylation | KSVVLMSHLGRPDGV CEEEEECCCCCCCCC | 20.52 | - | |
63 | Ubiquitination | KSVVLMSHLGRPDGV CEEEEECCCCCCCCC | 20.52 | - | |
69 | Acetylation | SHLGRPDGVPMPDKY CCCCCCCCCCCCCCC | 28.27 | - | |
69 | Ubiquitination | SHLGRPDGVPMPDKY CCCCCCCCCCCCCCC | 28.27 | - | |
72 | Sulfoxidation | GRPDGVPMPDKYSLE CCCCCCCCCCCCCCH | 6.61 | 30846556 | |
75 | Ubiquitination | DGVPMPDKYSLEPVA CCCCCCCCCCCHHHH | 30.76 | 21890473 | |
75 | Acetylation | DGVPMPDKYSLEPVA CCCCCCCCCCCHHHH | 30.76 | 19608861 | |
75 | Malonylation | DGVPMPDKYSLEPVA CCCCCCCCCCCHHHH | 30.76 | 26320211 | |
75 | Ubiquitination | DGVPMPDKYSLEPVA CCCCCCCCCCCHHHH | 30.76 | 21890473 | |
76 | Nitration | GVPMPDKYSLEPVAV CCCCCCCCCCHHHHH | 26.35 | - | |
76 | Phosphorylation | GVPMPDKYSLEPVAV CCCCCCCCCCHHHHH | 26.35 | 25159151 | |
77 | Phosphorylation | VPMPDKYSLEPVAVE CCCCCCCCCHHHHHH | 31.81 | 27259358 | |
78 | Acetylation | PMPDKYSLEPVAVEL CCCCCCCCHHHHHHH | 8.60 | - | |
78 | Ubiquitination | PMPDKYSLEPVAVEL CCCCCCCCHHHHHHH | 8.60 | - | |
86 | Ubiquitination | EPVAVELKSLLGKDV HHHHHHHHHHCCCCE | 26.08 | 21890473 | |
86 | 2-Hydroxyisobutyrylation | EPVAVELKSLLGKDV HHHHHHHHHHCCCCE | 26.08 | - | |
86 | Acetylation | EPVAVELKSLLGKDV HHHHHHHHHHCCCCE | 26.08 | 19608861 | |
86 | Ubiquitination | EPVAVELKSLLGKDV HHHHHHHHHHCCCCE | 26.08 | 21890473 | |
87 | Phosphorylation | PVAVELKSLLGKDVL HHHHHHHHHCCCCEE | 41.26 | 22617229 | |
91 | 2-Hydroxyisobutyrylation | ELKSLLGKDVLFLKD HHHHHCCCCEEEECC | 44.63 | - | |
91 | Acetylation | ELKSLLGKDVLFLKD HHHHHCCCCEEEECC | 44.63 | 23954790 | |
91 | Ubiquitination | ELKSLLGKDVLFLKD HHHHHCCCCEEEECC | 44.63 | 21890473 | |
97 | 2-Hydroxyisobutyrylation | GKDVLFLKDCVGPEV CCCEEEECCCCCHHH | 41.57 | - | |
97 | Acetylation | GKDVLFLKDCVGPEV CCCEEEECCCCCHHH | 41.57 | 19608861 | |
97 | Other | GKDVLFLKDCVGPEV CCCEEEECCCCCHHH | 41.57 | 29775581 | |
97 | Ubiquitination | GKDVLFLKDCVGPEV CCCEEEECCCCCHHH | 41.57 | 21890473 | |
99 | S-nitrosocysteine | DVLFLKDCVGPEVEK CEEEECCCCCHHHHH | 3.49 | - | |
99 | S-nitrosylation | DVLFLKDCVGPEVEK CEEEECCCCCHHHHH | 3.49 | 22178444 | |
103 | Acetylation | LKDCVGPEVEKACAN ECCCCCHHHHHHHCC | 58.33 | - | |
103 | Ubiquitination | LKDCVGPEVEKACAN ECCCCCHHHHHHHCC | 58.33 | - | |
105 | Acetylation | DCVGPEVEKACANPA CCCCHHHHHHHCCCC | 33.02 | - | |
106 | Acetylation | CVGPEVEKACANPAA CCCHHHHHHHCCCCC | 54.67 | 23954790 | |
106 | Ubiquitination | CVGPEVEKACANPAA CCCHHHHHHHCCCCC | 54.67 | - | |
108 | S-nitrosocysteine | GPEVEKACANPAAGS CHHHHHHHCCCCCCC | 5.79 | - | |
108 | Glutathionylation | GPEVEKACANPAAGS CHHHHHHHCCCCCCC | 5.79 | 22555962 | |
108 | S-nitrosylation | GPEVEKACANPAAGS CHHHHHHHCCCCCCC | 5.79 | 18335467 | |
108 | S-palmitoylation | GPEVEKACANPAAGS CHHHHHHHCCCCCCC | 5.79 | 29575903 | |
113 | Acetylation | KACANPAAGSVILLE HHHCCCCCCCEEEEE | 16.43 | - | |
113 | Ubiquitination | KACANPAAGSVILLE HHHCCCCCCCEEEEE | 16.43 | - | |
115 | Phosphorylation | CANPAAGSVILLENL HCCCCCCCEEEEECC | 10.97 | 21712546 | |
118 | Acetylation | PAAGSVILLENLRFH CCCCCEEEEECCEEE | 4.62 | - | |
118 | Ubiquitination | PAAGSVILLENLRFH CCCCCEEEEECCEEE | 4.62 | - | |
123 | Methylation | VILLENLRFHVEEEG EEEEECCEEEEEECC | 31.07 | 115487217 | |
128 | Acetylation | NLRFHVEEEGKGKDA CCEEEEEECCCCCCC | 71.59 | - | |
128 | Ubiquitination | NLRFHVEEEGKGKDA CCEEEEEECCCCCCC | 71.59 | - | |
131 | N6-malonyllysine | FHVEEEGKGKDASGN EEEEECCCCCCCCCC | 67.10 | - | |
131 | Acetylation | FHVEEEGKGKDASGN EEEEECCCCCCCCCC | 67.10 | 19608861 | |
131 | Malonylation | FHVEEEGKGKDASGN EEEEECCCCCCCCCC | 67.10 | 26320211 | |
131 | Ubiquitination | FHVEEEGKGKDASGN EEEEECCCCCCCCCC | 67.10 | 19608861 | |
133 | Acetylation | VEEEGKGKDASGNKV EEECCCCCCCCCCCC | 54.32 | 23749302 | |
136 | Phosphorylation | EGKGKDASGNKVKAE CCCCCCCCCCCCCCC | 53.70 | 28857561 | |
139 | Ubiquitination | GKDASGNKVKAEPAK CCCCCCCCCCCCHHH | 48.95 | - | |
141 | Acetylation | DASGNKVKAEPAKIE CCCCCCCCCCHHHHH | 48.95 | 23749302 | |
141 | Malonylation | DASGNKVKAEPAKIE CCCCCCCCCCHHHHH | 48.95 | 26320211 | |
141 | Ubiquitination | DASGNKVKAEPAKIE CCCCCCCCCCHHHHH | 48.95 | - | |
146 | Ubiquitination | KVKAEPAKIEAFRAS CCCCCHHHHHHHHHH | 52.36 | 21890473 | |
146 | 2-Hydroxyisobutyrylation | KVKAEPAKIEAFRAS CCCCCHHHHHHHHHH | 52.36 | - | |
146 | Acetylation | KVKAEPAKIEAFRAS CCCCCHHHHHHHHHH | 52.36 | 19608861 | |
146 | Ubiquitination | KVKAEPAKIEAFRAS CCCCCHHHHHHHHHH | 52.36 | 21890473 | |
153 | Phosphorylation | KIEAFRASLSKLGDV HHHHHHHHHHHHCCE | 28.99 | 25159151 | |
155 | Phosphorylation | EAFRASLSKLGDVYV HHHHHHHHHHCCEEE | 24.28 | 29523821 | |
156 | Ubiquitination | AFRASLSKLGDVYVN HHHHHHHHHCCEEEC | 62.88 | 21890473 | |
156 | Ubiquitination | AFRASLSKLGDVYVN HHHHHHHHHCCEEEC | 62.88 | 21890473 | |
156 | 2-Hydroxyisobutyrylation | AFRASLSKLGDVYVN HHHHHHHHHCCEEEC | 62.88 | - | |
156 | Acetylation | AFRASLSKLGDVYVN HHHHHHHHHCCEEEC | 62.88 | 23954790 | |
156 | Malonylation | AFRASLSKLGDVYVN HHHHHHHHHCCEEEC | 62.88 | 26320211 | |
156 | Ubiquitination | AFRASLSKLGDVYVN HHHHHHHHHCCEEEC | 62.88 | 21890473 | |
161 | Nitration | LSKLGDVYVNDAFGT HHHHCCEEECCCCCC | 9.77 | - | |
161 | Phosphorylation | LSKLGDVYVNDAFGT HHHHCCEEECCCCCC | 9.77 | 28796482 | |
163 | Acetylation | KLGDVYVNDAFGTAH HHCCEEECCCCCCCC | 19.73 | - | |
163 | Ubiquitination | KLGDVYVNDAFGTAH HHCCEEECCCCCCCC | 19.73 | - | |
164 | Ubiquitination | LGDVYVNDAFGTAHR HCCEEECCCCCCCCC | 32.98 | - | |
168 | Phosphorylation | YVNDAFGTAHRAHSS EECCCCCCCCCCCHH | 16.91 | 28857561 | |
171 | Ubiquitination | DAFGTAHRAHSSMVG CCCCCCCCCCHHCCC | 31.37 | 21890473 | |
174 | O-linked_Glycosylation | GTAHRAHSSMVGVNL CCCCCCCHHCCCCCC | 21.10 | 31911580 | |
174 | Phosphorylation | GTAHRAHSSMVGVNL CCCCCCCHHCCCCCC | 21.10 | 20068231 | |
175 | O-linked_Glycosylation | TAHRAHSSMVGVNLP CCCCCCHHCCCCCCC | 13.97 | 31911580 | |
175 | Phosphorylation | TAHRAHSSMVGVNLP CCCCCCHHCCCCCCC | 13.97 | 20068231 | |
176 | Sulfoxidation | AHRAHSSMVGVNLPQ CCCCCHHCCCCCCCC | 3.22 | 21406390 | |
184 | Ubiquitination | VGVNLPQKAGGFLMK CCCCCCCCCCCEECH | 47.24 | 21890473 | |
184 | 2-Hydroxyisobutyrylation | VGVNLPQKAGGFLMK CCCCCCCCCCCEECH | 47.24 | - | |
184 | Acetylation | VGVNLPQKAGGFLMK CCCCCCCCCCCEECH | 47.24 | 25953088 | |
184 | Ubiquitination | VGVNLPQKAGGFLMK CCCCCCCCCCCEECH | 47.24 | 21906983 | |
188 | Ubiquitination | LPQKAGGFLMKKELN CCCCCCCEECHHHHH | 6.19 | 21890473 | |
191 | 2-Hydroxyisobutyrylation | KAGGFLMKKELNYFA CCCCEECHHHHHHHH | 45.29 | - | |
191 | Acetylation | KAGGFLMKKELNYFA CCCCEECHHHHHHHH | 45.29 | 23749302 | |
191 | Malonylation | KAGGFLMKKELNYFA CCCCEECHHHHHHHH | 45.29 | 32601280 | |
191 | Methylation | KAGGFLMKKELNYFA CCCCEECHHHHHHHH | 45.29 | 24883637 | |
191 | Succinylation | KAGGFLMKKELNYFA CCCCEECHHHHHHHH | 45.29 | - | |
191 | Succinylation | KAGGFLMKKELNYFA CCCCEECHHHHHHHH | 45.29 | - | |
191 | Ubiquitination | KAGGFLMKKELNYFA CCCCEECHHHHHHHH | 45.29 | - | |
192 | Ubiquitination | AGGFLMKKELNYFAK CCCEECHHHHHHHHH | 54.17 | 21890473 | |
192 | Acetylation | AGGFLMKKELNYFAK CCCEECHHHHHHHHH | 54.17 | - | |
192 | Ubiquitination | AGGFLMKKELNYFAK CCCEECHHHHHHHHH | 54.17 | 21890473 | |
192 | 2-Hydroxyisobutyrylation | AGGFLMKKELNYFAK CCCEECHHHHHHHHH | 54.17 | - | |
192 | Malonylation | AGGFLMKKELNYFAK CCCEECHHHHHHHHH | 54.17 | 26320211 | |
192 | Ubiquitination | AGGFLMKKELNYFAK CCCEECHHHHHHHHH | 54.17 | 21890473 | |
196 | Nitration | LMKKELNYFAKALES ECHHHHHHHHHHHHC | 19.96 | - | |
196 | Phosphorylation | LMKKELNYFAKALES ECHHHHHHHHHHHHC | 19.96 | 27273156 | |
199 | Ubiquitination | KELNYFAKALESPER HHHHHHHHHHHCCCC | 43.54 | 21890473 | |
199 | Acetylation | KELNYFAKALESPER HHHHHHHHHHHCCCC | 43.54 | 19608861 | |
199 | Ubiquitination | KELNYFAKALESPER HHHHHHHHHHHCCCC | 43.54 | 21890473 | |
203 | Phosphorylation | YFAKALESPERPFLA HHHHHHHCCCCCCCH | 32.67 | 29255136 | |
216 | Ubiquitination | LAILGGAKVADKIQL CHHHCCHHHHHHHHH | 41.03 | 21890473 | |
216 | 2-Hydroxyisobutyrylation | LAILGGAKVADKIQL CHHHCCHHHHHHHHH | 41.03 | - | |
216 | Acetylation | LAILGGAKVADKIQL CHHHCCHHHHHHHHH | 41.03 | 23954790 | |
216 | Other | LAILGGAKVADKIQL CHHHCCHHHHHHHHH | 41.03 | 29775581 | |
216 | Ubiquitination | LAILGGAKVADKIQL CHHHCCHHHHHHHHH | 41.03 | 21890473 | |
220 | Ubiquitination | GGAKVADKIQLINNM CCHHHHHHHHHHHHH | 23.71 | 21890473 | |
220 | 2-Hydroxyisobutyrylation | GGAKVADKIQLINNM CCHHHHHHHHHHHHH | 23.71 | - | |
220 | Acetylation | GGAKVADKIQLINNM CCHHHHHHHHHHHHH | 23.71 | 23954790 | |
220 | Malonylation | GGAKVADKIQLINNM CCHHHHHHHHHHHHH | 23.71 | 26320211 | |
220 | Ubiquitination | GGAKVADKIQLINNM CCHHHHHHHHHHHHH | 23.71 | 21890473 | |
227 | Sulfoxidation | KIQLINNMLDKVNEM HHHHHHHHHHHHHHH | 4.41 | 21406390 | |
234 | Sulfoxidation | MLDKVNEMIIGGGMA HHHHHHHHHCCCHHH | 1.97 | 28465586 | |
236 | Ubiquitination | DKVNEMIIGGGMAFT HHHHHHHCCCHHHHH | 3.96 | 21890473 | |
239 | Acetylation | NEMIIGGGMAFTFLK HHHHCCCHHHHHHHH | 10.07 | - | |
239 | Ubiquitination | NEMIIGGGMAFTFLK HHHHCCCHHHHHHHH | 10.07 | - | |
240 | Sulfoxidation | EMIIGGGMAFTFLKV HHHCCCHHHHHHHHH | 2.91 | 30846556 | |
243 | Phosphorylation | IGGGMAFTFLKVLNN CCCHHHHHHHHHHCC | 20.65 | 22817900 | |
244 | Ubiquitination | GGGMAFTFLKVLNNM CCHHHHHHHHHHCCC | 5.12 | - | |
246 | Ubiquitination | GMAFTFLKVLNNMEI HHHHHHHHHHCCCCC | 40.25 | - | |
251 | Ubiquitination | FLKVLNNMEIGTSLF HHHHHCCCCCCCCCC | 3.75 | - | |
251 | Sulfoxidation | FLKVLNNMEIGTSLF HHHHHCCCCCCCCCC | 3.75 | 21406390 | |
255 | O-linked_Glycosylation | LNNMEIGTSLFDEEG HCCCCCCCCCCCHHH | 28.11 | 31911580 | |
255 | Phosphorylation | LNNMEIGTSLFDEEG HCCCCCCCCCCCHHH | 28.11 | 21712546 | |
256 | Phosphorylation | NNMEIGTSLFDEEGA CCCCCCCCCCCHHHH | 23.09 | 21712546 | |
263 | Acetylation | SLFDEEGAKIVKDLM CCCCHHHHHHHHHHH | 11.15 | - | |
263 | Ubiquitination | SLFDEEGAKIVKDLM CCCCHHHHHHHHHHH | 11.15 | - | |
264 | 2-Hydroxyisobutyrylation | LFDEEGAKIVKDLMS CCCHHHHHHHHHHHH | 59.91 | - | |
264 | Acetylation | LFDEEGAKIVKDLMS CCCHHHHHHHHHHHH | 59.91 | 25953088 | |
264 | Ubiquitination | LFDEEGAKIVKDLMS CCCHHHHHHHHHHHH | 59.91 | 21906983 | |
267 | Ubiquitination | EEGAKIVKDLMSKAE HHHHHHHHHHHHHHH | 48.93 | 21890473 | |
267 | 2-Hydroxyisobutyrylation | EEGAKIVKDLMSKAE HHHHHHHHHHHHHHH | 48.93 | - | |
267 | Acetylation | EEGAKIVKDLMSKAE HHHHHHHHHHHHHHH | 48.93 | 19608861 | |
267 | Ubiquitination | EEGAKIVKDLMSKAE HHHHHHHHHHHHHHH | 48.93 | 21890473 | |
271 | Phosphorylation | KIVKDLMSKAEKNGV HHHHHHHHHHHHCCC | 35.69 | 22673903 | |
272 | 2-Hydroxyisobutyrylation | IVKDLMSKAEKNGVK HHHHHHHHHHHCCCE | 46.75 | - | |
272 | Acetylation | IVKDLMSKAEKNGVK HHHHHHHHHHHCCCE | 46.75 | 25953088 | |
272 | Ubiquitination | IVKDLMSKAEKNGVK HHHHHHHHHHHCCCE | 46.75 | - | |
275 | Acetylation | DLMSKAEKNGVKITL HHHHHHHHCCCEEEE | 64.95 | 7964599 | |
279 | Ubiquitination | KAEKNGVKITLPVDF HHHHCCCEEEEECCE | 31.22 | - | |
281 | Phosphorylation | EKNGVKITLPVDFVT HHCCCEEEEECCEEE | 21.20 | 21712546 | |
288 | Phosphorylation | TLPVDFVTADKFDEN EEECCEEEHHHCCCC | 29.18 | 21712546 | |
291 | Ubiquitination | VDFVTADKFDENAKT CCEEEHHHCCCCCCC | 52.85 | 21890473 | |
291 | 2-Hydroxyisobutyrylation | VDFVTADKFDENAKT CCEEEHHHCCCCCCC | 52.85 | - | |
291 | Acetylation | VDFVTADKFDENAKT CCEEEHHHCCCCCCC | 52.85 | 19608861 | |
291 | Ubiquitination | VDFVTADKFDENAKT CCEEEHHHCCCCCCC | 52.85 | 21890473 | |
294 | Ubiquitination | VTADKFDENAKTGQA EEHHHCCCCCCCCCC | 63.32 | - | |
295 | Acetylation | TADKFDENAKTGQAT EHHHCCCCCCCCCCE | 48.89 | - | |
295 | Ubiquitination | TADKFDENAKTGQAT EHHHCCCCCCCCCCE | 48.89 | - | |
297 | Ubiquitination | DKFDENAKTGQATVA HHCCCCCCCCCCEEE | 65.84 | - | |
298 | Phosphorylation | KFDENAKTGQATVAS HCCCCCCCCCCEEEC | 31.92 | 21406692 | |
302 | Phosphorylation | NAKTGQATVASGIPA CCCCCCCEEECCCCC | 14.55 | 21406692 | |
304 | Ubiquitination | KTGQATVASGIPAGW CCCCCEEECCCCCCC | 9.55 | - | |
305 | Phosphorylation | TGQATVASGIPAGWM CCCCEEECCCCCCCC | 32.68 | 21406692 | |
312 | Sulfoxidation | SGIPAGWMGLDCGPE CCCCCCCCCCCCCCH | 3.60 | 30846556 | |
316 | Glutathionylation | AGWMGLDCGPESSKK CCCCCCCCCCHHHHH | 13.57 | 22555962 | |
320 | Phosphorylation | GLDCGPESSKKYAEA CCCCCCHHHHHHHHH | 51.06 | 21406692 | |
321 | Phosphorylation | LDCGPESSKKYAEAV CCCCCHHHHHHHHHH | 31.35 | 21406692 | |
322 | 2-Hydroxyisobutyrylation | DCGPESSKKYAEAVT CCCCHHHHHHHHHHH | 60.11 | - | |
322 | Acetylation | DCGPESSKKYAEAVT CCCCHHHHHHHHHHH | 60.11 | 25953088 | |
322 | Ubiquitination | DCGPESSKKYAEAVT CCCCHHHHHHHHHHH | 60.11 | - | |
323 | 2-Hydroxyisobutyrylation | CGPESSKKYAEAVTR CCCHHHHHHHHHHHH | 52.20 | - | |
323 | Acetylation | CGPESSKKYAEAVTR CCCHHHHHHHHHHHH | 52.20 | 23749302 | |
323 | Other | CGPESSKKYAEAVTR CCCHHHHHHHHHHHH | 52.20 | 29775581 | |
323 | Ubiquitination | CGPESSKKYAEAVTR CCCHHHHHHHHHHHH | 52.20 | 19608861 | |
324 | Phosphorylation | GPESSKKYAEAVTRA CCHHHHHHHHHHHHH | 17.26 | 26437602 | |
325 | Acetylation | PESSKKYAEAVTRAK CHHHHHHHHHHHHHH | 13.72 | - | |
325 | Ubiquitination | PESSKKYAEAVTRAK CHHHHHHHHHHHHHH | 13.72 | - | |
329 | Phosphorylation | KKYAEAVTRAKQIVW HHHHHHHHHHHHHHH | 31.77 | 26437602 | |
332 | Ubiquitination | AEAVTRAKQIVWNGP HHHHHHHHHHHHCCC | 36.95 | 21906983 | |
333 | Acetylation | EAVTRAKQIVWNGPV HHHHHHHHHHHCCCC | 34.19 | - | |
333 | Ubiquitination | EAVTRAKQIVWNGPV HHHHHHHHHHHCCCC | 34.19 | 21890473 | |
353 | Acetylation | EAFARGTKALMDEVV HHHHHHHHHHHHHHH | 42.20 | 23749302 | |
353 | Malonylation | EAFARGTKALMDEVV HHHHHHHHHHHHHHH | 42.20 | 26320211 | |
353 | Ubiquitination | EAFARGTKALMDEVV HHHHHHHHHHHHHHH | 42.20 | - | |
354 | Acetylation | AFARGTKALMDEVVK HHHHHHHHHHHHHHH | 14.14 | - | |
354 | Ubiquitination | AFARGTKALMDEVVK HHHHHHHHHHHHHHH | 14.14 | - | |
356 | Sulfoxidation | ARGTKALMDEVVKAT HHHHHHHHHHHHHHH | 5.02 | 21406390 | |
360 | Acetylation | KALMDEVVKATSRGC HHHHHHHHHHHCCCC | 3.08 | - | |
360 | Ubiquitination | KALMDEVVKATSRGC HHHHHHHHHHHCCCC | 3.08 | - | |
361 | Ubiquitination | ALMDEVVKATSRGCI HHHHHHHHHHCCCCE | 51.64 | 21890473 | |
361 | 2-Hydroxyisobutyrylation | ALMDEVVKATSRGCI HHHHHHHHHHCCCCE | 51.64 | - | |
361 | Acetylation | ALMDEVVKATSRGCI HHHHHHHHHHCCCCE | 51.64 | 23954790 | |
361 | Malonylation | ALMDEVVKATSRGCI HHHHHHHHHHCCCCE | 51.64 | 26320211 | |
361 | Ubiquitination | ALMDEVVKATSRGCI HHHHHHHHHHCCCCE | 51.64 | 21890473 | |
363 | Phosphorylation | MDEVVKATSRGCITI HHHHHHHHCCCCEEE | 17.15 | 28857561 | |
364 | Phosphorylation | DEVVKATSRGCITII HHHHHHHCCCCEEEE | 31.38 | 28857561 | |
365 | Methylation | EVVKATSRGCITIIG HHHHHHCCCCEEEEC | 39.38 | 115487225 | |
367 | Glutathionylation | VKATSRGCITIIGGG HHHHCCCCEEEECCC | 2.11 | 22555962 | |
367 | S-nitrosylation | VKATSRGCITIIGGG HHHHCCCCEEEECCC | 2.11 | 22178444 | |
367 | S-palmitoylation | VKATSRGCITIIGGG HHHHCCCCEEEECCC | 2.11 | 29575903 | |
369 | Phosphorylation | ATSRGCITIIGGGDT HHCCCCEEEECCCCC | 15.60 | 28857561 | |
378 | Ubiquitination | IGGGDTATCCAKWNT ECCCCCEEEECCCCC | 15.37 | - | |
378 | Phosphorylation | IGGGDTATCCAKWNT ECCCCCEEEECCCCC | 15.37 | 28857561 | |
379 | S-nitrosylation | GGGDTATCCAKWNTE CCCCCEEEECCCCCC | 1.65 | 22178444 | |
379 | S-palmitoylation | GGGDTATCCAKWNTE CCCCCEEEECCCCCC | 1.65 | 29575903 | |
380 | S-nitrosylation | GGDTATCCAKWNTED CCCCEEEECCCCCCC | 3.66 | 22178444 | |
380 | S-palmitoylation | GGDTATCCAKWNTED CCCCEEEECCCCCCC | 3.66 | 29575903 | |
382 | 2-Hydroxyisobutyrylation | DTATCCAKWNTEDKV CCEEEECCCCCCCCE | 27.36 | - | |
382 | Acetylation | DTATCCAKWNTEDKV CCEEEECCCCCCCCE | 27.36 | 23954790 | |
382 | Ubiquitination | DTATCCAKWNTEDKV CCEEEECCCCCCCCE | 27.36 | - | |
388 | 2-Hydroxyisobutyrylation | AKWNTEDKVSHVSTG CCCCCCCCEEEEECC | 39.13 | - | |
388 | Acetylation | AKWNTEDKVSHVSTG CCCCCCCCEEEEECC | 39.13 | 23954790 | |
388 | Ubiquitination | AKWNTEDKVSHVSTG CCCCCCCCEEEEECC | 39.13 | - | |
390 | Phosphorylation | WNTEDKVSHVSTGGG CCCCCCEEEEECCCC | 24.74 | 20068231 | |
393 | Phosphorylation | EDKVSHVSTGGGASL CCCEEEEECCCCHHH | 18.86 | 20068231 | |
394 | Phosphorylation | DKVSHVSTGGGASLE CCEEEEECCCCHHHH | 38.46 | 25693802 | |
399 | Phosphorylation | VSTGGGASLELLEGK EECCCCHHHHHHCCC | 26.17 | 25849741 | |
406 | Acetylation | SLELLEGKVLPGVDA HHHHHCCCCCCCCCH | 31.09 | 23954790 | |
406 | Ubiquitination | SLELLEGKVLPGVDA HHHHHCCCCCCCCCH | 31.09 | 19608861 | |
415 | O-linked_Glycosylation | LPGVDALSNI----- CCCCCHHCCC----- | 33.91 | 31911580 | |
415 | Phosphorylation | LPGVDALSNI----- CCCCCHHCCC----- | 33.91 | 29507054 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PGK1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PGK1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TPIS_HUMAN | TPI1 | physical | 22939629 | |
TBA4A_HUMAN | TUBA4A | physical | 22939629 | |
SCOT1_HUMAN | OXCT1 | physical | 22939629 | |
AK1A1_HUMAN | AKR1A1 | physical | 26344197 | |
ALDR_HUMAN | AKR1B1 | physical | 26344197 | |
AK1BA_HUMAN | AKR1B10 | physical | 26344197 | |
ALDOA_HUMAN | ALDOA | physical | 26344197 | |
ALDOC_HUMAN | ALDOC | physical | 26344197 | |
ARPC3_HUMAN | ARPC3 | physical | 26344197 | |
XPO2_HUMAN | CSE1L | physical | 26344197 | |
EF1A1_HUMAN | EEF1A1 | physical | 26344197 | |
EF2_HUMAN | EEF2 | physical | 26344197 | |
ENOA_HUMAN | ENO1 | physical | 26344197 | |
ENOG_HUMAN | ENO2 | physical | 26344197 | |
ENOB_HUMAN | ENO3 | physical | 26344197 | |
G3P_HUMAN | GAPDH | physical | 26344197 | |
PSB2_HUMAN | PSMB2 | physical | 26344197 | |
SF01_HUMAN | SF1 | physical | 26344197 | |
1433S_HUMAN | SFN | physical | 26344197 | |
SFPQ_HUMAN | SFPQ | physical | 26344197 | |
TAGL2_HUMAN | TAGLN2 | physical | 26344197 | |
TAGL3_HUMAN | TAGLN3 | physical | 26344197 | |
TPIS_HUMAN | TPI1 | physical | 26344197 | |
1433E_HUMAN | YWHAE | physical | 26344197 | |
1433T_HUMAN | YWHAQ | physical | 26344197 |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-11; LYS-30; LYS-48; LYS-75;LYS-86; LYS-97; LYS-131; LYS-146; LYS-199; LYS-267; LYS-291; LYS-323AND LYS-406, AND MASS SPECTROMETRY. | |
Malonylation | |
Reference | PubMed |
"The first identification of lysine malonylation substrates and itsregulatory enzyme."; Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,Dai J., Verdin E., Ye Y., Zhao Y.; Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011). Cited for: MALONYLATION AT LYS-131. | |
N6-malonyllysine | |
Reference | PubMed |
"The first identification of lysine malonylation substrates and itsregulatory enzyme."; Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,Dai J., Verdin E., Ye Y., Zhao Y.; Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011). Cited for: MALONYLATION AT LYS-131. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203 AND THR-243, ANDMASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-136, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-196, AND MASSSPECTROMETRY. |